Pharmaceutical News

RSS

Incidence of stroke has risen steadily among marijuana users, show studies

11th World Stroke Congress brings together leading international stroke experts and an unparalleled scientific program covering epidemiology, prevention, acute care, rehabilitation and recovery in 100s of sessions and oral posters.

19 Oct 2018

Many primary care doctors are still prescribing sedative drugs for older adults

Despite years of warnings that older adults shouldn't take sedative drugs that put them at risk of injury and death, a new study reveals how many primary care doctors are still prescribing them, how often, and exactly where.

19 Oct 2018

New urea sorbent could speed up the development of wearable artificial kidney

There just aren't enough kidney transplants available for the millions of people with renal failure.

19 Oct 2018

Study finds changes in antiepileptic drug metabolism during different trimesters of pregnancy

During pregnancy, the numerous physiological changes a woman's body undergoes can alter the way medications are metabolized, the rate at which they are cleared, and their overall effectiveness.

17 Oct 2018

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic clinical trial for Type 2 diabetes - one of the nation's fastest growing chronic diseases.

17 Oct 2018

Misuse of prescription opioids or benzodiazepines associated with suicidal thoughts

Misuse of prescription opioids or benzodiazepines (such as Xanax) was associated with suicidal ideation in a study of US older adults.

17 Oct 2018

Antidepressant treatment may lead to improvements in sleep quality of patients with depression

In a study of 15 patients affected by major depressive disorder and complaining of insomnia, initiating treatment with vortioxetine for their depressive symptoms led to significant improvements in subjective sleep quality and daytime sleepiness.

17 Oct 2018

Hundreds of dietary supplements shown to contain unapproved drugs

An investigation has found that hundreds of over-the-counter dietary supplements contain unapproved pharmaceutical ingredients.

16 Oct 2018

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride (generic name, product name in the United States: BELVIQ, product name for once-daily formulation in the United States: BELVIQ XR, "lorcaserin") in 17 countries in Latin America and the Caribbean, excluding Brazil, to Eurofarma Laboratorios S.A. which has a business foundation in Latin America.

16 Oct 2018

Drugmakers funnel millions to lawmakers; a few dozen get $100,000-plus

A new Kaiser Health News database tracks campaign donations from drugmakers over the past 10 years.

16 Oct 2018

Purdue researchers develop new chemical process to find better drug 'fits' for patients

When a medication doesn't "fit" the body quite right, the results can be devastating. Such is the case for thalidomide, which was prescribed in the 1950s and 1960s as a sedative or hypnotic, even for pregnant women.

16 Oct 2018

Trump administration, pharma exchange verbal volleys on drug-price transparency

The Trump administration and drugmakers are squaring off over a proposal to show drug prices in television ads.

16 Oct 2018

Researchers examine SSRI use during pregnancy and major gestational malformations

A comprehensive new review article presents the most current understanding of the role selective serotonin reuptake inhibitors play in increased risk of multiple diverse gestational malformations and takes aim at the ongoing debate over whether SSRIs as a drug class can cause these malformations.

16 Oct 2018

Ketamine can be considered as alternative to opioids for short-term pain control in ED

Intravenous, low-dose ketamine is as effective as intravenous morphine in the control of acute pain in adults in the emergency department.

15 Oct 2018

Allele awarded NIH grant to develop nanoantibody therapies for treatment of sepsis

The National Institute of General Medical Sciences of NIH has awarded a Small Business Innovative Research grant to Allele Biotechnology and Pharmaceuticals to develop new single-domain nanoantibody therapies for the treatment of sepsis.

15 Oct 2018

NHS tackles prescription fraud to save millions

The NHS has taken measures to stop patients from wrongfully claiming prescriptions for free. Prescription frauds, according to sources, cost the NHS £256 million annually. These measures would help reduce these costs by half.

15 Oct 2018

Unapproved pharmaceutical ingredients identified in many over-the-counter dietary supplements

Potentially harmful and undeclared pharmaceuticals were identified in more than 700 over-the-counter dietary supplements in an analysis of U.S. Food and Drug Administration warnings from 2007 through 2016.

12 Oct 2018

Hidden drugs and danger lurk in over-the-counter supplements, study finds

Everyone has seen the ads or the products on the shelves. A dietary supplement that promises to make consumers skinny, without dieting or exercise. Or the one that will bulk them up and turn them into the envy of other weightlifters at the gym. Not to mention the one to make them perform better in the bedroom.

12 Oct 2018

Working Towards a Sustainable Future for the NHS

An interview with Jennifer Lee, Director of Market Access and Advocacy at Janssen UK, the pharmaceutical company of Johnson & Johnson, discussing the importance of innovation in the private sector and making new technologies available to the NHS.

12 Oct 2018

Antidepressants can be used to treat Alzheimer’s disease

Scientists at the University of Waterloo have discovered that antidepressant medications can be used to treat Alzheimer’s disease.

12 Oct 2018

Pharmaceutical News

Incidence of stroke has risen steadily among marijuana users, show studies

Many primary care doctors are still prescribing sedative drugs for older adults

New urea sorbent could speed up the development of wearable artificial kidney

Study finds changes in antiepileptic drug metabolism during different trimesters of pregnancy

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

Misuse of prescription opioids or benzodiazepines associated with suicidal thoughts

Antidepressant treatment may lead to improvements in sleep quality of patients with depression

Hundreds of dietary supplements shown to contain unapproved drugs

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Drugmakers funnel millions to lawmakers; a few dozen get $100,000-plus

Purdue researchers develop new chemical process to find better drug 'fits' for patients

Trump administration, pharma exchange verbal volleys on drug-price transparency

Researchers examine SSRI use during pregnancy and major gestational malformations

Ketamine can be considered as alternative to opioids for short-term pain control in ED

Allele awarded NIH grant to develop nanoantibody therapies for treatment of sepsis

NHS tackles prescription fraud to save millions

Unapproved pharmaceutical ingredients identified in many over-the-counter dietary supplements

Hidden drugs and danger lurk in over-the-counter supplements, study finds

Working Towards a Sustainable Future for the NHS

Antidepressants can be used to treat Alzheimer’s disease

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News